1.
Nurs Clin North Am
; 58(2): 165-181, 2023 06.
Article
in English
| MEDLINE
| ID: mdl-37105652
ABSTRACT
In the United States, the opioid epidemic and COVID-19-related substance use have exacerbated the overall incidence of substance use disorders (SUDs). Medication-assisted therapy (MAT), or cognitive and behavioral therapy that combines medications that reduce substance use or acute withdrawal symptoms, has dramatically improved outcomes for SUD patients, including preventing mortality. With recent US Congressional funding for MAT, patients presenting for acute care on MAT-related medications will continue to increase. Nurses should be aware of these medications' mechanism of action, typical side effects, and implications on treating acute pain to optimize their care.
Subject(s)
COVID-19 , Opioid-Related Disorders , Substance-Related Disorders , Humans , United States , Behavior Therapy , Opioid-Related Disorders/drug therapy
2.
J Am Acad Dermatol
; 89(6): 1245-1246, 2023 12.
Article
in English
| MEDLINE
| ID: mdl-36813135